OTC Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide - 2016

Oct, 2016   |   104  Pages   |   MarketLine   |   Format : PDF
Summary

The BRIC OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the BRIC otc pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC otc pharmaceuticals market
- Leading company profiles reveal details of key otc pharmaceuticals market players BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC otc pharmaceuticals market with five year forecasts by both value and volume
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

Synopsis

Essential resource for top-line data and analysis covering the BRIC otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

Reasons To Buy

- What was the size of the BRIC otc pharmaceuticals market by value in 2015?
- What will be the s
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
BRIC OTC Pharmaceuticals
Industry Outlook
OTC Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

List of Tables

Table 1: BRIC otc pharmaceuticals industry, revenue($m), 2011-20
Table 2: BRIC otc pharmaceuticals industry, revenue($m), 2011-15
Table 3: BRIC otc pharmaceuticals industry, revenue($m), 2015-20
Table 4: Brazil OTC pharmaceuticals market value: $ million, 201115
Table 5: Brazil OTC pharmaceuticals market category segmentation: $ million, 2015
Table 6: Brazil OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 7: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Table 8: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Table 9: Brazil OTC pharmaceuticals market value forecast: $ million, 201520
Table 10: Brazil size of population (million), 201115
Table 11: Brazil gdp (constant 2005 prices, $ billion), 201115
Table 12: Brazil gdp (current prices, $ billion), 201115
Table 13: Brazil inflation, 201115
Table 14: Brazil consumer price index (absolute), 201115
Table 15: Brazil exchange rate, 201115
Table 16: China OTC pharmaceuticals market value: $ million, 201115
Table 17: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 18: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 19: China OTC pharmaceuticals market share: % share, by value, 2015
Table 20: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 21: China OTC pharmaceuticals market value forecast: $ million, 201520
Table 22: China size of population (million), 201115
Table 23: China gdp (constant 2005 prices, $ billion), 201115
Table 24: China gdp (current prices, $ billion), 201115
Table 25: China inflation, 201115
Table 26: China consumer price index (absolute), 201115
Table 27: China exchange rate, 201115
Table 28: India OTC pharmaceuticals market value: $ million, 201115
Table 29: India OTC pharmaceuticals market category segmentation: $ million, 2015
Table 30: India OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 31: India OTC pharmaceuticals market share: % share, by value, 2015
Table 32: India OTC pharmaceuticals market distribution: % share, by value, 2015
Table 33: India OTC pharmaceuticals market value forecast: $ million, 201520
Table 34: India size of population (million), 201115
Table 35: India gdp (constant 2005 prices, $ billion), 201115
Table 36: India gdp (current prices, $ billion), 201115
Table 37: India inflation, 201115
Table 38: India consumer price index (absolute), 201115
Table 39: India exchange rate, 201115
Table 40: Russia OTC pharmaceuticals market value: $ million, 201115
Table 41: Russia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 42: Russia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 43: Russia OTC pharmaceuticals market share: % share, by value, 2015
Table 44: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 45: Russia OTC pharmaceuticals market value forecast: $ million, 201520
Table 46: Russia size of population (million), 201115
Table 47: Russia gdp (constant 2005 prices, $ billion), 201115
Table 48: Russia gdp (current prices, $ billion), 201115
Table 49: Russia inflation, 201115
Table 50: Russia consumer price index (absolute), 201115
Table 51: Russia exchange rate, 201115
Table 52: Abbott Laboratories: key facts
Table 53: Abbott Laboratories: key financials ($)
Table 54: Abbott Laboratories: key financial ratios
Table 55: GlaxoSmithKline Plc: key facts
Table 56: GlaxoSmithKline Plc: key financials ($)
Table 57: GlaxoSmithKline Plc: key financials ()
Table 58: GlaxoSmithKline Plc: key financial ratios
Table 59: Johnson & Johnson: key facts
Table 60: Johnson & Johnson: key financials ($)
Table 61: Johnson & Johnson: key financial ratios
Table 62: Sanofi SA: key facts
Table 63: Sanofi SA: key financials ($)
Table 64: Sanofi SA: key financials ()
Table 65: Sanofi SA: key financial ratios
Table 66: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts
Table 67: Nin Jiom Medicines Manufactory Ltd: key facts
Table 68: Cipla Limited: key facts
Table 69: Cipla Limited: key financials ($)
Table 70: Cipla Limited: key financials (Rs.)
Table 71: Cipla Limited: key financial ratios
Table 72: Dabur India Limited: key facts
Table 73: Dabur India Limited: key financials ($)
Table 74: Dabur India Limited: key financials (Rs.)
Table 75: Dabur India Limited: key financial ratios
Table 76: JSC ELFA: key facts
Table 77: The Menarini Group: key facts
Table 78: The Menarini Group: key financials ($)
Table 79: The Menarini Group: key financials ()
Table 80: The Menarini Group: key financial ratios
Table 81: Pharmstandard OJSC: key facts
Table 82: Pharmstandard OJSC: key financials ($)
Table 83: Pharmstandard OJSC: key financials (RUB)
Table 84: Pharmstandard OJSC: key financial ratios

List of Figures

Figure 1: BRIC otc pharmaceuticals industry, revenue($m), 2011-20
Figure 2: BRIC otc pharmaceuticals industry, revenue($m), 2011-15
Figure 3: BRIC otc pharmaceuticals industry, revenue($m), 2015-20
Figure 4: Brazil OTC pharmaceuticals market value: $ million, 201115
Figure 5: Brazil OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 6: Brazil OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 7: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Figure 8: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 9: Brazil OTC pharmaceuticals market value forecast: $ million, 201520
Figure 10: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2015
Figure 11: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2015
Figure 12: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2015
Figure 13: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2015
Figure 14: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2015
Figure 15: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2015
Figure 16: China OTC pharmaceuticals market value: $ million, 201115
Figure 17: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 18: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 19: China OTC pharmaceuticals market share: % share, by value, 2015
Figure 20: China OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 21: China OTC pharmaceuticals market value forecast: $ million, 201520
Figure 22: Forces driving competition in the OTC pharmaceuticals market in China, 2015
Figure 23: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
Figure 24: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
Figure 25: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
Figure 26: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
Figure 27: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
Figure 28: India OTC pharmaceuticals market value: $ million, 201115
Figure 29: India OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 30: India OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 31: India OTC pharmaceuticals market share: % share, by value, 2015
Figure 32: India OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 33: India OTC pharmaceuticals market value forecast: $ million, 201520
Figure 34: Forces driving competition in the OTC pharmaceuticals market in India, 2015
Figure 35: Drivers of buyer power in the OTC pharmaceuticals market in India, 2015
Figure 36: Drivers of supplier power in the OTC pharmaceuticals market in India, 2015
Figure 37: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2015
Figure 38: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2015
Figure 39: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2015
Figure 40: Russia OTC pharmaceuticals market value: $ million, 201115
Figure 41: Russia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 42: Russia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 43: Russia OTC pharmaceuticals market share: % share, by value, 2015
Figure 44: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 45: Russia OTC pharmaceuticals market value forecast: $ million, 201520
Figure 46: Forces driving competition in the OTC pharmaceuticals market in Russia, 2015
Figure 47: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2015
Figure 48: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2015
Figure 49: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2015
Figure 50: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2015
Figure 51: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2015
Figure 52: Abbott Laboratories: revenues & profitability
Figure 53: Abbott Laboratories: assets & liabilities
Figure 54: GlaxoSmithKline Plc: revenues & profitability
Figure 55: GlaxoSmithKline Plc: assets & liabilities
Figure 56: Johnson & Johnson: revenues & profitability
Figure 57: Johnson & Johnson: assets & liabilities
Figure 58: Sanofi SA: revenues & profitability
Figure 59: Sanofi SA: assets & liabilities
Figure 60: Cipla Limited: revenues & profitability
Figure 61: Cipla Limited: assets & liabilities
Figure 62: Dabur India Limited: revenues & profitability
Figure 63: Dabur India Limited: assets & liabilities
Figure 64: Pharmstandard OJSC: revenues & profitability
Figure 65: Pharmstandard OJSC: assets & liabilities
OTC Drugs Markets in China
China's demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer con
Women's Body, Hand and Footcare - China
The Chinese body, hand and footcare market is the largest in the world due to population size, although it displays significant untapped potential for growth. With income levels rising across the country, the subsequent emergence of the Chinese middle class is likely to be a driving factor for
Research Report on China's OTC Drug Market, 2013-2017
Since OTC drugs are mainly used by consumers without a physician's prescription in treating certain common ailments which are easy for self-diagnosis and self-treatment, the structure of their terminal market is relatively stable. The Top 4 categories of OTC drugs in Chinese market include c
The 2016-2021 Outlook for OTC Healthcare Products in Greater China
This econometric study covers the latent demand outlook for OTC healthcare products across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrativ
The 2013-2018 Outlook for Steel Heating Boilers with Maximum 15 P.s.i. and Scotch-Type, Horizontal Fire Box, and All Other Hot Water Heating Boilers with at Least 400,001 BTU Per Hour Excluding Parts in Greater China
This econometric study covers the latent demand outlook for steel heating boilers with maximum 15 p.s.i. and scotch-type, horizontal fire box, and all other hot water heating boilers with at least 400,001 BTU per hour excluding parts across the regions of Greater China, including provinces, autonomo

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: